{
    "2019-12-24": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Allergan (AGN) Gets FDA Approval for Migraine Drug Ubrelvy",
                "features": {
                    "keywords": [
                        "Allergan",
                        "FDA Approval",
                        "Migraine Drug",
                        "Ubrelvy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Buy These 5 Low-Beta Stocks to Counter Market Volatility",
                "features": {
                    "keywords": [
                        "Low-Beta Stocks",
                        "Market Volatility",
                        "Investment Strategy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "general market"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}